Short answer · Medically reviewed summary · Last updated: 2026-05-08
Congenital Hyperinsulinism is a genetic condition caused by mutations in genes that regulate insulin secretion, and while it is often hereditary, it can also arise from spontaneous, de novo mutations. The inheritance pattern depends on the specific gene involved, with autosomal recessive patterns being the most common, though autosomal dominant forms also occur. Is Congenital Hyperinsulinism hereditary? Yes, Congenital Hyperinsulinism is a genetic disorder.
Is Congenital Hyperinsulinism hereditary?
Is Congenital Hyperinsulinism hereditary? The genetic component explained in plain language, reviewed against medical sources, with patient experiences.
Congenital Hyperinsulinism is a genetic condition caused by mutations in genes that regulate insulin secretion, and while it is often hereditary, it can also arise from spontaneous, de novo mutations. The inheritance pattern depends on the specific gene involved, with autosomal recessive patterns being the most common, though autosomal dominant forms also occur.
Is Congenital Hyperinsulinism hereditary?
Yes, Congenital Hyperinsulinism is a genetic disorder. It is "hereditary" when a pathogenic mutation is passed from carrier parents to their child. However, it can also be "genetic" without being inherited, meaning the mutation occurred spontaneously (de novo) in the affected individual. Because Congenital Hyperinsulinism involves over 15 known genes—including ABCC8 and KCNJ11—the clinical presentation and inheritance risk vary significantly based on the specific molecular diagnosis.
What are the inheritance patterns of Congenital Hyperinsulinism?
The inheritance of Congenital Hyperinsulinism is complex and determined by the specific gene mutation identified:
- Autosomal Recessive: The most common form; both parents are typically asymptomatic carriers, and there is a 25% risk of passing the condition to each child.
- Autosomal Dominant: A single copy of the mutated gene from one parent is sufficient to cause the condition, resulting in a 50% risk of inheritance per pregnancy.
- De Novo Mutations: Many cases of Congenital Hyperinsulinism occur due to new mutations in the child, meaning neither parent carries the gene mutation.
When is genetic testing recommended?
Genetic testing is essential for all patients diagnosed with Congenital Hyperinsulinism. It is recommended as soon as possible after clinical diagnosis to guide surgical and medical treatment plans, such as determining if the child may respond to diazoxide or require a pancreatectomy. Genetic counseling is vital for families to understand their specific recurrence risk and to discuss reproductive options like preimplantation genetic testing (PGT) for future pregnancies.
Next steps
- Consult a pediatric endocrinologist and a clinical geneticist to discuss molecular testing.
- Connect with the Congenital Hyperinsulinism community at DiseaseMaps.org to share experiences with others.
- Request a referral to a genetic counselor to review family history and inheritance risks.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Congenital Hyperinsulinism
- Orphanet: Hyperinsulinemic hypoglycemia
- OMIM (Online Mendelian Inheritance in Man): Hyperinsulinemic Hypoglycemia, Familial
- Congenital Hyperinsulinism International (CHI)
